Yasir B. Al-Wakeel's Net Worth
$262 Thousand
Who is Yasir B. Al-Wakeel?
Yasir B. Al-Wakeel does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kronos Bio, Inc., MAXCYTE, INC., Neon Therapeutics, Inc., and MERRIMACK PHARMACEUTICALS INC.
SEC CIK
Yasir B. Al-Wakeel's CIK is 0001650691
Past Insider Trading and Trends
2022 was Yasir B. Al-Wakeel's most active year for acquiring shares with 5 total transactions. Yasir B. Al-Wakeel's most active month to acquire stocks was the month of January. 2020 was Yasir B. Al-Wakeel's most active year for disposing of shares, totalling 6 transactions. Yasir B. Al-Wakeel's most active month to dispose stocks was the month of April. 2018 saw Yasir B. Al-Wakeel paying a total of $99,997.80 for 17,241 shares, this is the most they've acquired in one year. In 2023 Yasir B. Al-Wakeel cashed out on 18,643 shares for a total of $32,516.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kronos Bio, Inc. (KRON) Snapshot price: $0.9601
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.70% | -9.62K |
$1.75 | -$16,851.87 | 346.1K |
Jul 6
| |||
Form 4
| -2.47% | -9.03K |
$1.74 | -$15,664.62 | 355.72K |
Feb 24
| |||
Form 4
| +61.51% | 138.91K |
—
|
—
| 364.75K |
Feb 15
| |||
Form 4
| +32.83% | 53.6K |
—
|
—
| 216.84K |
Jul 25
| |||
Form 4
| +48.89% | 53.6K |
—
|
—
| 163.24K |
Feb 15
| |||
Form 4
| +194.58% | 72.42K |
—
|
—
| 109.64K |
Dec 9
| |||
Form 4
| +16.42% | 5.25K |
$19.00 | $99,750.00 | 37.22K |
Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MAXCYTE, INC. (MXCT) Snapshot price: $3.79
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 21.37K |
—
|
—
| 21.37K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neon Therapeutics, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -196.97K |
—
|
—
|
0
|
May 6
| |||
Form 4
| -2.42% | -4.89K |
$1.50 | -$7,336.50 | 196.97K |
Feb 29
| |||
Form 4
| -2.60% | -5.38K |
$1.51 | -$8,131.35 | 201.86K |
Feb 25
| |||
Form 4
| +45.70% | 65K |
—
|
—
| 207.24K |
Jan 12
| |||
Form 4
| +111.54% | 75K |
—
|
—
| 142.24K |
Nov 25
| |||
Form 4
| +290.01% | 50K |
—
|
—
| 67.24K |
Feb 27
| |||
Form 4
|
∞
| 17.24K |
$5.80 | $99,997.80 | 17.24K |
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MERRIMACK PHARMACEUTICALS INC (MACK) No price found
CFO and Head Corp Dev
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||